Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Mark
VANCOUVER, British Columbia, May 17, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40 ml units of its SYNC 25 CBD oil to the.
Emerald Health Therapeutics to Participate in Cowen Toronto Cannabis Summit
VANCOUVER, British Columbia, May 15, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in Cowen’s Toronto Cannabis Summit on May.
Emerald Health Therapeutics Expands Adult-Use Cannabis Distribution to Additional Provinces
OTCQX: EMHTF) has been authorized by PEI Cannabis and Manitoba Liquor & Lotteries Corporation to supply Emerald-branded cannabis products into those provinces. “We are pleased to have the opportunity...
Cannabis Stocks Sink as Market Sentiment Dampens
Cannabis Stocks Sink as Market Sentiment DampensCannabis-sector ETFsThe cannabis sector has broadly fallen today as overall market sentiment has been dampened by US-China trade disputes. The Horizons Marijuana...
Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Grow
VANCOUVER, British Columbia, May 01, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and.
Emerald to Issue Shares in lieu of Cash due under for Verdélite Acquisition
Emerald Health Therapeutics, Inc. (EMH.V) (“Emerald” or the “Company”) today announced that the vendors (the "Vendors") of Verdélite Sciences, Inc. and Verdélite Property Holdings, Inc. (collectively,...
Disruptive GW Pharmaceuticals Is Exempt from Big Pharma’s Volatility
Due to increasing political pressure and public discontent, the pharmaceutical industry, as well as healthcare in general, has gone volatile. For instance, the benchmark exchange-traded fund VanEck Vectors...
Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year En
OTCQX: EMHTF) today announced that its 50%-owned joint venture, Pure Sunfarms, has completed planting of the final quadrants of its 1.1 million square foot Delta 3 greenhouse operation in Delta, BC. As...
Emerald Health Therapeutics to Present at Investment Conferences in April
OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, announced today that executives of the company will participate in multiple upcoming investment conferences.
Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec
OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has received its Standard Processing License from Health Canada. This license means that, in addition to Verdélite’s right to cultivate...
We’re different. We were formed by a team that has dedicated their working lives to the health sciences, helping people overcome everyday medical conditions to live better lives. We're focused on harnessing the complexity of the endocannabinoid system and the cannabis plant to create better-controlled outcomes for everyone.
Through scientific research, we want to create a world where there is greater knowledge and understanding of the health and wellness benefits of marijuana, and where people can make educated decisions without safety concerns or fear of stigma.
Health and wellness options come from either the traditional pharmaceutical world or the natural health world. Through the science of the endocannabinoid system and the cannabis plant we offer the best of both worlds – controlled, predictable, effective outcomes from a natural, plant-based source.
We serve everyday people – men and women with normal lives and normal jobs. Whether they are using our medical or adult-use marijuana products, they're using them for a purpose; they are looking for an outcome that will improve their quality of life.
At Emerald Health, extraordinary, cutting edge cannabis science meets human understanding. The outcome is the innovation and intellectual property needed to precisely deliver controlled, specific, predictable outcomes for the people we help.
Emerald uses state-of-the-art growing processes to grow our medical cannabis, such as high-intensity discharge (HID) lights and a steam-sterilized growing medium. Once marijuana growing is complete, every batch is tested at an independent third-party lab to ensure it meets the required standards.
Emerald Health Therapeutics cultivates medical cannabis using proven and standardized marijuana growing methods while applying their research capabilities to discover potential medicinal benefits of cannabis for the future.